Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Diabetes Therapy

Issue 2/2010

Content (5 Articles)

Open Access Review

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes

Abd A. Tahrani, Anthony H. Barnett

Open Access Original Research

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

Jian Chen, Sandy Williams, Samantha Ho, Howard Loraine, Deborah Hagan, Jean M. Whaley, John N. Feder

Open Access Original Research

Development and pilot of a low-literacy diabetes education book using social marketing techniques

Michelle Kavin, Raquel M. Añel-Tiangco, David T. Mauger, Robert A. Gabbay

Open Access Review

The management of diabetic ketoacidosis in children

Arlan L. Rosenbloom

Open Access Original Research

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients

Junji Kozawa, Hiromi Iwahashi, Kohei Okita, Yukiyoshi Okauchi, Akihisa Imagawa, Iichiro Shimomura

Aug 10
Issue: 1/2010
Mar 11
Issue: 1/2011

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits